Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic SyndromesInterventions: Drug: cyclophosphamide; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic bone marrow transplantation; Radiation: radiation therapySponsors: Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)Active, not recruiting - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Marrow Transplant | Cancer | Cancer & Oncology | Chronic Myeloproliferative Neoplasm | Hematology | Leukemia | Lymphoma | Prograf | Research | Tacrolimus | Transplants